Do you want to read an article? Please log in or register.
Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis
Related content
COMMENTED
Immunotherapy
Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes
★ 0
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
J Autoimmun
Lombardi A, Concepcion E, Hou H, Arib H, Mezei M, Osman R, Tomer Y
doi: 10.1016/j.jaut.2020.102543
T Cells
Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children
Clin Immunol.
Vecchione A, Gerosa J, Di Fonte R, Jofra T, Pia CM, Napoleone V, Ippolito E, Galvani G, Ragogna F, Stabilini A, Bianconi E, Grogan P, Bonura C, Bonfanti R, Frontino G, Nano R, Melzi R, De Pellegrin M, Laurenzi A, Meschi F, Barera G, Rigamonti A, Indirli R, Bosi E, Piemonti L, Aiuti A, Battaglia M, Fousteri G
doi: 10.1016/j.clim.2019.108319.
Autoimmune Disease
Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases
J Autoimmun.
Marziale A, Bettacchioli E, Picart G, Nafai S, Galinat H, Meroni PL, Frostegard J, PRECISESADS Clinical Consortium., Alarcon-Riquelme ME, Renaudineau Y
doi: 10.1016/j.jaut.2020.102524.
Autoimmune Disease
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
Nature.
Saevarsdottir S, Olafsdottir TA, Ivarsdottir EV, Halldorsson GH, Gunnarsdottir K, Sigurdsson A, Johannesson A, Sigurdsson JK, Juliusdottir T, Lund SH, Arnthorsson AO, Styrmisdottir EL, Gudmundsson J, Grondal GM, Steinsson K, Alfredsson L, Askling J, Benediktsson R, Bjarnason R, Geirsson AJ, Gudbjornsson B, Gudjonsson H, Hjaltason H, Hreidarsson AB, Klareskog L, Kockum I, Kristjansdottir H, Love TJ, Ludviksson BR, Olsson T, Onundarson PT, Orvar KB, Padyukov L, Sigurgeirsson B, Tragante V, Bjarnadottir K, Rafnar T, Masson G, Sulem P, Gudbjartsson DF, Melsted P, Thorleifsson G, Norddahl GL, Thorsteinsdottir U, Jonsdottir I, Stefansson K
doi: 10.1038/s41586-020-2436-0.
Psoriatic Arthritis
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study
Rheumatology (Oxford).
Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N; PROMPT study group
doi: 10.1093/rheumatology/key286.
Autoimmune Disease
Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity
J Immunol.
Stathopoulos P, Chastre A, Waters P, Irani S, Fichtner ML, Benotti ES, Guthridge JM, Seifert J, Nowak RJ, Buckner JH, Holers VM, James JA, Hafler DA, O'Connor KC
doi: 10.4049/jimmunol.1801295.
Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules
J Am Acad Dermatol.
Ben-Shachar S, Dubov T, Toledano-Alhadef H, Mashiah J, Sprecher E, Constantini S, Leshno M, Messiaen LM
doi: 10.1016/j.jaad.2017.02.027.
Osteoporosis
Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in coeliac disease
Aliment Pharmacol Ther.
Pekki H, Kurppa K, Mäki M, Huhtala H, Laurila K, Ilus T, Kaukinen K
doi: 10.1111/apt.14048.
COMMENTED
Further Publications Dermatology
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet
Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, Mao H, Cui X, Karanikas CA, Thieu VT
doi: 10.1016/S0140-6736(21)01324-6